1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Ropinirole |
| brand | String | Requip (IR), Requip XL (extended-release) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Dopamine agonists|Dopamine D2/D3 receptor agonist (non-ergot)]] • [[:Category:Antiparkinsonians|Antiparkinsonian]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000013-QINU`"', '"`UNIQ--vote-00000014-QINU`"' |
| starting_dose | String | Parkinson disease: 0.25 mg PO TID, titrate weekly. Restless legs syndrome: 0.25 mg PO 1-3 hours before bedtime, titrate to 4 mg/day if needed |
| preparations | String | IR tablets 0.25, 0.5, 1, 2, 3, 4, 5 mg; XL tablets 2, 4, 6, 8, 12 mg |
| fda_max | String | 24 mg/day (Parkinson disease); 4 mg/day (restless legs syndrome) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | Motor improvement over days at therapeutic dose |
| duration | String | TID dosing (IR); once-daily (XL) |
| halflife | String | ~6 hours'"`UNIQ--ref-00000015-QINU`"' |
| bioavailability | String | ~55% (oral)'"`UNIQ--ref-00000016-QINU`"' |
| pregnancy | String | Limited human data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
